Maria L. M.
- Country
- Spain
- Department
- ES10005: Reumatología
Research Overview
- Long-term Safety, Tolerability, and Efficacy of Bimekizumab in Adults with Active Psoriatic Arthritis: A Multicenter, Open-label Extension Study
- Efficacy and Safety of Subcutaneous Guselkumab in Bio-naive Patients with Active Psoriatic Arthritis Axial Disease: A Phase 4 Randomized, Double-blind, Placebo-controlled Study
- Efficacy and Safety of Subcutaneous Guselkumab in Active Psoriatic Arthritis: A Phase 3b Randomized, Double-blind, Placebo-controlled Study
Data & Insights
Has run more than one trial at 34 of 157 partner sites.
Specializations
Rheumatology Focus
The investigator specializes in treating psoriatic arthritis (PsA), with particular emphasis on managing both peripheral and axial manifestations of the disease.
- Joint Inflammation Management
- Axial Disease Assessment
- Long-term Disease Control
Their research involves evaluating novel therapeutic approaches for active PsA.
Therapeutic Expertise
The investigator works with advanced biological therapies, including targeted treatments such as IL-23 inhibitors and other innovative compounds.
- Biologic Treatment Assessment
- Treatment-naive Patient Care
- Symptom Reduction Strategies
Their work focuses on evaluating therapeutic efficacy in reducing PsA symptoms and signs.
Clinical Assessment
The investigator specializes in evaluating long-term safety profiles and therapeutic tolerability of new treatments for psoriatic arthritis.
- Safety Monitoring
- Treatment Response Assessment
- Long-term Outcome Evaluation
Their expertise includes monitoring subcutaneous administration of biologics in adult patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.